Correlation Between Cingulate Warrants and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Compass Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Compass Therapeutics.
Diversification Opportunities for Cingulate Warrants and Compass Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cingulate and Compass is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Compass Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 4.16 times more return on investment than Compass Therapeutics. However, Cingulate Warrants is 4.16 times more volatile than Compass Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Compass Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 5.19 in Cingulate Warrants on August 28, 2024 and sell it today you would lose (0.46) from holding Cingulate Warrants or give up 8.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Cingulate Warrants vs. Compass Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Compass Therapeutics |
Cingulate Warrants and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Compass Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Cingulate Warrants vs. Eliem Therapeutics | Cingulate Warrants vs. HCW Biologics | Cingulate Warrants vs. Scpharmaceuticals | Cingulate Warrants vs. Milestone Pharmaceuticals |
| Compass Therapeutics vs. Ideaya Biosciences | Compass Therapeutics vs. AnaptysBio | Compass Therapeutics vs. MeiraGTx Holdings PLC | Compass Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world |